C J Tack, P Smits. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Carbamates/classificationCarbamates/pharmacologyCarbamates/therapeutic useChromans/classificationChromans/pharmacologyChromans/therapeutic useCyclohexanes/classificationCyclohexanes/pharmacologyCyclohexanes/therapeutic useDiabetes Mellitus, Type 2/drug therapyHumansHypoglycemic Agents/classificationHypoglycemic Agents/pharmacologyHypoglycemic Agents/therapeutic useInsulin ResistanceMetformin/classificationMetformin/pharmacologyMetformin/therapeutic useNateglinidePhenylalanine/analogs & derivativesPhenylalanine/classificationPhenylalanine/pharmacologyPhenylalanine/therapeutic usePiperidines/classificationPiperidines/pharmacologyPiperidines/therapeutic useThiazoles/classificationThiazoles/pharmacologyThiazoles/therapeutic useThiazolidinedionesTroglitazone
Substances： See more » CarbamatesChromansCyclohexanesHypoglycemic AgentsPiperidinesThiazolesThiazolidinedionesNateglinidePhenylalaninerepaglinideMetforminTroglitazone
Year: 1999 PMID： 10593129 DOI： 10.1016/s0300-2977(99)00089-3
Source DB: PubMed Journal: Neth J Med ISSN： 0300-2977 Impact factor: 1.422